![(3AR,4S,5R,6AS)-4-[[[(1,1-二甲基乙基)二甲基硅基]氧基]甲基]六氢-5-[(四氢-2H-吡喃-2-基)氧基]-2H-环戊并[B]呋喃-2-酮, 65025-95-8, 结构式](https://yunshiji.oss-cn-shenzhen.aliyuncs.com/202411/01/2002268618800000201.gif)
|
|
(3AR,4S,5R,6AS)-4-[[[(1,1-二甲基乙基)二甲基硅基]氧基]甲基]六氢-5-[(四氢-2H-吡喃-2-基)氧基]-2H-环戊并[B]呋喃-2-酮
|
|
- CAS号:
- 65025-95-8
- 英文名:
- 4-(T-BUTYLDI-ME-SIO-ME)HEXA-H-5-(T-H-PYR AN -2-YLOXY)-CYCLOPENTA(B)FURAN-2-ON, 97
- 英文别名:
- Prostaglandin Impurity 2;4-(T-butyldi-me-sio-me)hexa-H-5-(T-H-pyran -2-ylo;(3aR,4S,5R,6aS)-4-(tert-Butyldimethylsilyloxymethyl)hexahydr...;(3aR,4S,5R,6aS)-(-)-(tert-Butyldimethylsilyloxymethyl)hexahydro-5-;4-(T-BUTYLDI-ME-SIO-ME)HEXA-H-5-(T-H-PYR -2-YLOXY)-CYCLOPENTA(B)FURAN-2-ON, 97;4-(T-BUTYLDI-ME-SIO-ME)HEXA-H-5-(T-H-PYR AN -2-YLOXY)-CYCLOPENTA(B)FURAN-2-ON, 97;(3AR,4S,5R,6aS)-4-(((tert-Butyldimethylsilyl)oxy)methyl)-5-((tetrahydro-2H-pyran-2-yl)oxy)hexa;(3AR,4S,5R,6aS)-4-(((tert-Butyldimethylsilyl)oxy)methyl)-5-((tetrahydro-2H-pyran-2-yl)oxy)hexahyd;(3aR,4S,5R,6aS)-(-)-(tert-ButyldiMethylsilyloxyMethyl)hexahydro-5-(tetrahydro-2H-pyran-2-yloxy)-2H-;(3aR,4S,5R,6aS)-4-(tert-Butyldimethylsilyloxy)methyl-5-tetrahydropyranyloxy-hexahydro-2H-cyclopenta[b]furan-2-one
- 中文名:
- (3AR,4S,5R,6AS)-4-[[[(1,1-二甲基乙基)二甲基硅基]氧基]甲基]六氢-5-[(四氢-2H-吡喃-2-基)氧基]-2H-环戊并[B]呋喃-2-酮
- 中文别名:
- 前列腺素杂质2;THP基COREY内酯;前列素中间体65025-95-8,65025-95-8;(3AR,4S,5R,6AS)-4-(叔丁基二甲基甲硅烷氧基)甲基-5-四氢吡喃氧基-六氢-2H-环戊[B]呋喃-2-酮;(3AR,4S,5R,6AS)-4-(((叔丁基二甲基甲硅烷基)氧基)甲基)-5-((四氢-2H-吡喃-2-基)氧基)六氢-2H-环戊[B]呋喃-2-酮;(3AR,4S,5R,6AS)-4-[[[(1,1-二甲基乙基)二甲基硅基]氧基]甲基]六氢-5-[(四氢-2H-吡喃-2-基)氧基]-2H-环戊并[B]呋喃-2-酮;(3AR,4S,5R,6AS)-4-[[[(1,1-二甲基乙基)二甲基硅烷基]氧基]甲基]六氢-5-[(四氢-2H-吡喃-2-基)氧基]-2H-环戊并[B]呋喃-2-酮(...)
- CBNumber:
- CB3504226
- 分子式:
- C19H34O5Si
- 分子量:
- 370.56
- MOL File:
- 65025-95-8.mol
|
|
|
VIP会员
400-6226-992
粤公网安备44196802000105号
